Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 177 Total
XYLO - Xylo Technologies Ltd. ADR - Stock Price Chart
TickerXYLO [NASD]
CompanyXylo Technologies Ltd. ADR
CountryIsrael
IndustryMedical Devices
Market Cap3.56MEPS (ttm)-23.59
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-32.16%
P/S0.06EPS next 5Y-
P/B0.23EPS Q/Q-1104.55%
Dividend-Sales Q/Q-36.36%
Insider Own0.06%Inst Own4.31%
Insider Trans0.00%Inst Trans0.08%
Short Float0.71%EarningsSep 02
Analyst Recom1.00Target Price12.00
Avg Volume12.83K52W Range2.70 - 8.83
Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carmel LironOfficerDec 09 '24Proposed Sale3.656,00021,912Dec 10 02:50 PM
Xylo Technologies Ltd.10% OwnerDec 03 '24Proposed Sale1.771,869,1533,308,401Dec 03 10:58 AM
CSTM - Constellium SE - Stock Price Chart
TickerCSTM [NYSE, RUT]
CompanyConstellium SE
CountryFrance
IndustryAluminum
Market Cap1.65BEPS (ttm)0.31
P/E36.87EPS this Y167.80%
Forward P/E7.19EPS next Y56.73%
PEG-EPS past 5Y-4.74%
P/S0.22EPS next 5Y-
P/B2.33EPS Q/Q-561.17%
Dividend-Sales Q/Q-0.79%
Insider Own10.05%Inst Own85.61%
Insider Trans0.00%Inst Trans-0.88%
Short Float1.54%EarningsFeb 20/b
Analyst Recom1.00Target Price16.75
Avg Volume1.33M52W Range9.04 - 23.20
Constellium SE is a holding company, which engages in the design and manufacture of rolled and extruded aluminum products. It operates through the following segments: Packaging and Automotive Rolled Products, Aerospace and Transportation, and Automotive Structures and Industry. The Packaging and Automotive Rolled Products segment includes the production in European and North American facilities. The Aerospace and Transportation segment involves the plate and sheet form, and limited volumes of extruded products. The Automotive Structures and Industry segment consists of extruded aluminum products and structural components, crash-management systems, body structures, side impact beams, and battery enclosures, fabricated hard and soft alloy extruded profiles. The company was founded on May 14, 2010 and is headquartered in Paris, France.
CGTL - Creative Global Technology Holdings Ltd - Stock Price Chart
TickerCGTL [NASD]
CompanyCreative Global Technology Holdings Ltd
CountryHong Kong
IndustrySpecialty Retail
Market Cap70.32MEPS (ttm)0.03
P/E128.12EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S15.42EPS next 5Y-
P/B40.58EPS Q/Q124.66%
Dividend-Sales Q/Q-32.55%
Insider Own93.29%Inst Own0.56%
Insider Trans0.00%Inst Trans0.12%
Short Float0.15%Earnings-
Analyst Recom-Target Price-
Avg Volume58.22K52W Range3.03 - 10.59
Creative Global Technology Holdings Ltd. engages in sourcing and reselling recycled consumer electronic devices through its subsidiary. The company was founded in 2016 and is headquartered in Hong Kong.
ICLK - iClick Interactive Asia Group Ltd ADR - Stock Price Chart
TickerICLK [NASD]
CompanyiClick Interactive Asia Group Ltd ADR
CountryHong Kong
IndustryAdvertising Agencies
Market Cap59.27MEPS (ttm)-1.17
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y9.18%
P/S0.59EPS next 5Y-
P/B2.08EPS Q/Q-2045.92%
Dividend-Sales Q/Q-44.19%
Insider Own-Inst Own11.98%
Insider Trans-Inst Trans-0.14%
Short Float-Earnings-
Analyst Recom3.00Target Price4.00
Avg Volume77.57K52W Range1.03 - 11.38
iClick Interactive Asia Group Ltd. is a holding company, which engages in the provision of an online marketing and data technology platform. It operates through the Marketing Solutions and Enterprise Solutions segments. The Marketing Solutions segment refers to the online marketing service business. The Enterprise Solutions segment reflects the results of the firm's SaaS products and services. The company was founded by Wing Hong Hsieh, Yau Ping Ng, and Jian Tang on February 3, 2010 and is headquartered in Hong Kong.
MAPS - WM Technology Inc - Stock Price Chart
TickerMAPS [NASD, RUT]
CompanyWM Technology Inc
CountryUSA
IndustrySoftware - Application
Market Cap208.38MEPS (ttm)-0.02
P/E-EPS this Y992.44%
Forward P/E7.35EPS next Y42.31%
PEG-EPS past 5Y-
P/S1.17EPS next 5Y175.93%
P/B4.48EPS Q/Q307.93%
Dividend-Sales Q/Q-2.46%
Insider Own24.09%Inst Own41.07%
Insider Trans-0.41%Inst Trans8.47%
Short Float3.90%EarningsMar 13/a
Analyst Recom2.00Target Price2.61
Avg Volume1.28M52W Range0.70 - 1.65
WM Technology, Inc. operates as an online cannabis marketplace. Its products include Weedmaps and Weedmaps for Business. It provides cannabis consumers with information regarding cannabis retailers and brands. The company was founded by Douglas Francis and Justin Hartfield in 2008 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANTHONY BAYDirectorMar 07 '25Proposed Sale1.307,5769,849Mar 05 04:43 PM
Camire BrianGENERAL COUNSELFeb 18 '25Sale1.3831,31243,214597,846Feb 20 04:05 PM
Francis DouglasChief Executive OfficerFeb 18 '25Sale1.3892,328127,4329,042,410Feb 20 04:05 PM
Camire BrianGENERAL COUNSELNov 18 '24Sale1.0227,84828,508629,158Nov 20 05:04 PM
Camire BrianGENERAL COUNSELAug 16 '24Sale1.0039,71239,903657,006Aug 20 04:09 PM
OLMA - Olema Pharmaceuticals Inc - Stock Price Chart
TickerOLMA [NASD, RUT]
CompanyOlema Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap306.82MEPS (ttm)-2.19
P/E-EPS this Y-9.60%
Forward P/E-EPS next Y-14.04%
PEG-EPS past 5Y-105.28%
P/S-EPS next 5Y-14.41%
P/B1.29EPS Q/Q-26.21%
Dividend-Sales Q/Q-
Insider Own20.05%Inst Own84.44%
Insider Trans-4.30%Inst Trans13.17%
Short Float15.04%EarningsNov 12/a
Analyst Recom1.00Target Price28.17
Avg Volume1.18M52W Range4.07 - 16.62
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bain Capital Life Sciences Inv10% OwnerJan 08 '25Buy5.76300,0001,727,3707,800,000Jan 13 04:34 PM
Graham G. WalmsleyDirectorDec 17 '24Sale6.75700,7614,730,1370Dec 17 07:52 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERDec 16 '24Option Exercise4.8714,00068,180129,509Dec 17 07:29 PM
Logos Opportunities Fund I LPAffiliateDec 13 '24Proposed Sale6.75700,7614,730,137Dec 13 04:37 PM
Harmon CyrusDirectorDec 10 '24Sale9.378,25677,359772,277Dec 11 07:56 PM
SDHC - Smith Douglas Homes Corp - Stock Price Chart
TickerSDHC [NYSE]
CompanySmith Douglas Homes Corp
CountryUSA
IndustryReal Estate - Development
Market Cap1.13BEPS (ttm)1.93
P/E11.46EPS this Y-4.35%
Forward P/E12.55EPS next Y2.13%
PEG3.35EPS past 5Y-
P/S1.25EPS next 5Y3.42%
P/B2.85EPS Q/Q-8.66%
Dividend-Sales Q/Q40.58%
Insider Own83.39%Inst Own18.51%
Insider Trans0.02%Inst Trans-0.23%
Short Float4.28%EarningsMar 12/b
Analyst Recom3.17Target Price25.20
Avg Volume107.58K52W Range19.52 - 39.50
Smith Douglas Homes Corp. engages in the business of designing, construction, and sale of single-family homes. The firm offers homes with single-level living, modern villas, and townhomes, functional two and three-story homes, with extra space for conveniences like laundry, flex offices, and lofts upstairs. It operates through the following geographical segments: Alabama, Atlanta, Charlotte, Houston, Nashville, and Raleigh. The company was founded by Thomas L. Bradbury in 2008 and is headquartered in Woodstock, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jackson Jeffrey TDirectorNov 19 '24Buy29.778,605256,18215,748Nov 21 04:00 PM
LSF - Laird Superfood Inc - Stock Price Chart
TickerLSF [AMEX]
CompanyLaird Superfood Inc
CountryUSA
IndustryPackaged Foods
Market Cap56.85MEPS (ttm)-0.19
P/E-EPS this Y-145.73%
Forward P/E-EPS next Y65.52%
PEG-EPS past 5Y-8.75%
P/S1.31EPS next 5Y-
P/B4.31EPS Q/Q-354.61%
Dividend-Sales Q/Q26.05%
Insider Own32.16%Inst Own15.70%
Insider Trans0.41%Inst Trans40.83%
Short Float0.58%EarningsFeb 26/a
Analyst Recom1.00Target Price13.00
Avg Volume78.27K52W Range0.76 - 10.90
Laird Superfood, Inc. engages in the manufacturing and marketing of plant-based and functional foods. Its products include creamers, coffees, instafuels, functional mushroom blends, active mixes, hydrate coconut waters, renew plant-based protein, and harvest snacks. The company was founded by Laird Hamilton and Paul W. Hodge Jr. in June 2015 and is headquartered in Boulder, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vieth Jason D.Chief Executive OfficerMar 04 '25Buy5.3710,00053,650684,969Mar 06 05:05 PM
Hamill AnnaChief Financial OfficerMar 05 '25Buy5.492,68314,738108,544Mar 06 04:58 PM
Hamill AnnaChief Financial OfficerMar 04 '25Buy5.719215,258105,861Mar 06 04:58 PM
Richie Steven LGeneral Counsel & SecretaryJul 05 '24Option Exercise1.5437,50057,875125,555Jul 08 09:50 PM
Barker Geoffrey TDirectorMar 15 '24Buy2.7950,000139,469179,057Mar 18 04:37 PM
EWTX - Edgewise Therapeutics Inc - Stock Price Chart
TickerEWTX [NASD, RUT]
CompanyEdgewise Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.68BEPS (ttm)-1.45
P/E-EPS this Y-29.58%
Forward P/E-EPS next Y-12.24%
PEG-EPS past 5Y-49.00%
P/S-EPS next 5Y-11.98%
P/B5.81EPS Q/Q10.03%
Dividend-Sales Q/Q-
Insider Own29.38%Inst Own78.81%
Insider Trans-1.77%Inst Trans-5.62%
Short Float11.99%EarningsMar 03/b
Analyst Recom1.22Target Price47.44
Avg Volume976.05K52W Range14.90 - 38.12
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Russell Alan JChief Scientific OfficerFeb 05 '25Option Exercise0.188,0151,44322,878Feb 07 04:38 PM
Russell Alan JChief Scientific OfficerFeb 06 '25Option Exercise0.181,20021616,063Feb 07 04:38 PM
Russell Alan JChief Scientific OfficerFeb 05 '25Sale30.028,015240,62314,863Feb 07 04:38 PM
Russell Alan JChief Scientific OfficerFeb 06 '25Sale30.131,20036,15314,863Feb 07 04:38 PM
KOCH KEVINPresident and CEOFeb 06 '25Option Exercise13.1190011,79915,378Feb 07 04:38 PM
MLYS - Mineralys Therapeutics Inc - Stock Price Chart
TickerMLYS [NASD, RUT]
CompanyMineralys Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap525.26MEPS (ttm)-3.64
P/E-EPS this Y-7.43%
Forward P/E-EPS next Y4.73%
PEG-EPS past 5Y-170.42%
P/S-EPS next 5Y-2.10%
P/B2.75EPS Q/Q-61.06%
Dividend-Sales Q/Q-
Insider Own50.67%Inst Own54.66%
Insider Trans-0.34%Inst Trans8.13%
Short Float7.10%EarningsFeb 12/b
Analyst Recom1.00Target Price31.67
Avg Volume271.16K52W Range8.24 - 15.25
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rodman David MalcomChief Medical OfficerFeb 12 '25Option Exercise1.086,3486,856164,520Feb 13 05:29 PM
Levy Adam ScottCFO and SecretaryJan 13 '25Sale9.1010,75797,864226,097Jan 15 09:46 PM
Rodman David MalcomChief Medical OfficerJan 13 '25Option Exercise0.8411,3679,567158,172Jan 15 09:45 PM
Congleton JonChief Executive OfficerJan 13 '25Sale9.0618,333166,082877,608Jan 15 09:44 PM
Congleton JonOfficerJan 13 '25Proposed Sale9.0618,333166,083Jan 13 06:34 PM
1101112131415161718